Just a moment...

Top
Help
Upgrade to AI Tools

We've upgraded AI Tools on TaxTMI with two powerful modes:

1. Basic
Quick overview summary answering your query with referencesCategory-wise results to explore all relevant documents on TaxTMI

2. Advanced
• Includes everything in Basic
Detailed report covering:
     -   Overview Summary
     -   Governing Provisions [Acts, Notifications, Circulars]
     -   Relevant Case Laws
     -   Tariff / Classification / HSN
     -   Expert views from TaxTMI
     -   Practical Guidance with immediate steps and dispute strategy

• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.Help Us Improve - by giving the rating with each AI Result:

Explore AI Tools

Powered by Weblekha - Building Scalable Websites

×

By creating an account you can:

Logo TaxTMI
>
Call Us / Help / Feedback

Contact Us At :

E-mail: [email protected]

Call / WhatsApp at: +91 99117 96707

For more information, Check Contact Us

FAQs :

To know Frequently Asked Questions, Check FAQs

Most Asked Video Tutorials :

For more tutorials, Check Video Tutorials

Submit Feedback/Suggestion :

Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters0/2000
TMI Blog
Home / RSS

India’s pharma exports cross USD 28 bn till Feb, grow over 5 pc

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....ndia’s pharma exports cross USD 28 bn till Feb, grow over 5 pc<BR>Customs & Trade<BR>Dated:- 4-4-2026<BR>PTI<BR>Hyderabad, Apr 4 (PTI) India’s pharmaceutical exports stood at over USD 28 billion up to February of the current financial year, registering a growth of more than 5 per cent compared to the same period last year, a top official said on Saturday. K Raja Bhanu, Director General of t....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....he Pharmaceuticals Export Promotion Council of India (Pharmexcil), said the sector, currently valued at around USD 60 billion, is projected to grow to USD 130 billion by 2030. “Despite global challenges, pharmaceutical exports have been among the few sectors to maintain growth momentum. Exports during April–February FY26 stood at USD 28.29 billion, reflecting a growth of 5.6 per cent compar....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....ed to the same period in FY25, led by formulations, biologicals, vaccines and AYUSH products,” he said, addressing the inaugural session of the 'Chintan Shivir: Scaling Up Pharma Exports'. Bhanu added that exports reached USD 30.47 billion in FY2024–25, marking a year-on-year growth of 9.4 per cent despite global pricing pressures and trade volatility. Pharmexcil Chairman Namit Joshi sai....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....d India is likely to end the current financial year at levels similar to FY25. Looking ahead, Bhanu said Pharmexcil aims to achieve USD 65 billion in exports by 2030 through policy prioritisation, market diversification beyond traditional geographies, increased FDI inflows and improved regulatory efficiency. India ranks third globally in pharmaceutical production by volume, with exports reac....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....hing over 200 markets worldwide, he said. Notably, more than 60 per cent of India’s pharmaceutical exports are directed towards highly regulated markets, underscoring the industry's quality and compliance standards. The United States accounts for 34 per cent of exports, followed by Europe at 19 per cent, he added. Joshi said tariff-related issues in 2025 led to higher procurement of med....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....icines worth USD 1.6 billion in the US, above normal levels, which is expected to impact FY26 figures. “That is why we expect to end up close to last year’s performance, with some growth coming from that,” he said. He added that exact figures would be available only after the March data is released. PTI GDK SSK =============<BR> News - Press release - PIB....